Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
01/2009
01/07/2009CN101341126A Antibacterial active 5-chinolin derivative
01/07/2009CN101337944A P-38 kinase inhibitors
01/07/2009CN100448874C N-aroyl cyclic amines
01/07/2009CN100448873C Cycloalkyl derivatives of 3-hydroxy-4-pyridinones
01/07/2009CN100448869C Anilinopyrazole derivatives useful for the treatment of diabetes
01/07/2009CN100448853C Current carrier transmtiting material with high-effect and balancing electronic cavity transmitting performance
01/06/2009US7473790 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
01/06/2009US7473787 Bicyclic [3.1.0] derivatives as glycine transporter inhibitors
01/06/2009US7473701 Substituted indazoles, compositions containing them, method of production and use
01/06/2009US7473699 antibiotic; Gram-positive pathogens (Staphylococci, Enterococci, and Streptococci ), MRSA and MRCNS; resistance to vancomycin and E. faecium to both aminoglycosides and beta--lactams; gram negative strains H.influenzae, M.catarrhalis and chlamydia; improved activity against mono-amine oxidase (MAO)
01/06/2009US7473691 Pyrazole compounds useful as protein kinase inhibitors
01/06/2009CA2478374C N3 alkylated benzimidazole derivatives as mek inhibitors
01/06/2009CA2369504C Pyrazole compositions useful as inhibitors of erk
01/06/2009CA2295446C Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same
01/06/2009CA2227851C Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives
01/06/2009CA2216546C 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2-one derivatives having pde iv and cytokine inhibiting activity
01/06/2009CA2120319C Pharmaceutical for the treatment of skin disorders
01/02/2009DE60224401T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure
01/01/2009US20090005580 Compounds, compositions and methods
01/01/2009US20090005567 Process for the preparation of 4-(8-chloro-5,6-dihydro-11h-benzo (5,6)-cyclohepta-(1,2b) -pyridin-11-ylidene)-1-piperidinecarboxylic acid ethyl ester (loratadine)
01/01/2009US20090005421 Novel Pyridine Derivatives
01/01/2009US20090005391 Tricyclo Substituted Amides
01/01/2009US20090005380 Cyclohexyl derivatives
01/01/2009US20090005376 1-Alkoxy 1H-Imidazo Ring Systems and Methods
01/01/2009US20090005375 Acetyl coenzyme a carboxylase inhibitors
01/01/2009US20090005374 Imidazopyridinyl thiazolyl histone deacetylase inhibitors
01/01/2009US20090005369 Oxazolidinone Compounds and Compositions and Methods Related Thereto
01/01/2009US20090005365 Therapeutic pyrazolonaphthyridine derivatives
01/01/2009US20090005363 Organic Compounds
01/01/2009US20090005354 New Amino Derivatives and Their Use as Pharmaceuticals
01/01/2009US20090005250 Substituted 2,4-diamino-1,3,5-triazines, processes for their use as herbicides and crop growth regulators
01/01/2009US20090004185 Amino-substituted quinazoline derivatives as inhibitors of beta-catenin/tcf-4 pathway and cancer treatment agents
01/01/2009US20090004106 Radioligands for the 5 -Ht1b Receptor
12/2008
12/31/2008WO2009001915A1 Substituted imidazole compound and use thereof
12/31/2008WO2009001784A1 N-phenyl-methanamine derivative and pest control agent containing the same
12/31/2008WO2009001730A1 Novel compound having β secretase inhibitory activity
12/31/2008WO2009001203A2 An improved process for the preparation of aprepitant
12/31/2008WO2009001192A2 Novel compounds and their use
12/31/2008WO2009001132A1 Pyrazinone derivatives and their use in the treatment of lung diseases
12/31/2008WO2009001127A1 Cyanocyclopropylcarboxamides as cathepsin inhibitors
12/31/2008WO2009000819A1 5-phenyl-1,3,4-oxadiazol-2-yl-acetyl-4-piperidinyl derivatives as cgrp receptor antagonists
12/31/2008WO2009000757A1 Piperazine compounds with herbicidal action
12/31/2008WO2009000662A1 Isoxazole-imidazole derivatives
12/31/2008WO2008140066A3 Pyridone derivatives as p38a mapk inhibitors
12/31/2008WO2008135181A3 Insecticidal substituted 2-aminoindanes
12/31/2008WO2008082487A3 Novel jnk inhibitors
12/31/2008WO2006078753B1 N-substituted heterocyclic sulfonamides
12/31/2008WO2006078753A4 N-substituted heterocyclic sulfonamides
12/31/2008EP2009012A1 Novel compound having heterocyclic ring
12/31/2008EP2009011A1 Nitrogen-containing heterocyclic compound
12/31/2008EP2009006A1 Ureide derivative and use thereof for medical purposes
12/31/2008EP2009005A1 Azolecarboxamide derivative
12/31/2008EP2009001A1 Method for manufacturing dioxazine derivatives
12/31/2008EP2007789A2 Hcv/hiv inhibitors and their uses
12/31/2008EP2007759A1 Isoxazole derivatives as calcium channel blockers
12/31/2008EP2007753A1 Heterocyclic gaba alpha subtype selective receptor modulators
12/31/2008EP2007750A1 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine d3 receptors
12/31/2008EP2007749A2 Tetralines antagonists of the h-3 receptor
12/31/2008EP2007748A2 Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives
12/31/2008EP2007747A1 Process for preparing heterocyclic derivatives
12/31/2008EP2007729A1 Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
12/31/2008EP2007720A1 Benzamide derivatives as inhibitors of histone deacetylase
12/31/2008EP2007393A2 Thiazole and thiophene analogues, and their use in treating autoimmune diseases and cancers
12/31/2008EP1546099B1 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists
12/31/2008EP1435785B1 Iminobenzoxazines, iminobenzothiazines and iminoquinazolines for controlling invertebrate pests
12/31/2008CN101336239A Substituted oxindol-derivatives, medicaments containing said derivatives and use thereof
12/31/2008CN101336237A Pyrimidinyl aryl urea derivatives being fgf inhibitors
12/31/2008CN101333438A Material with bipolar carrier transmission performance and uses thereof
12/31/2008CN101333196A 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
12/31/2008CN101333192A Biaryl substituted pyrazoles as sodium channel blockers
12/31/2008CN100447139C Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds
12/31/2008CN100447137C P-38 kinase inhibitors
12/31/2008CN100447136C New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors
12/31/2008CN100446767C Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods
12/31/2008CA2692255A1 Novel compounds and their use
12/31/2008CA2691215A1 Pyrazinone derivatives and their use in the treatment of lung diseases
12/31/2008CA2690975A1 Isoxazole-imidazole derivatives
12/31/2008CA2686224A1 Piperazine compounds having herbicidal action
12/30/2008US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
12/30/2008US7470790 for treatment of various neurodegeneration, including that from stroke, Alzheimer's disease, Parkinson's disease, and Huntington's disease; [6-(1-benzyl-4-hydroxy-pyrrolidin-3-ylmethyl)-pyridin-2-yl]-carbamic acid tert-butyl ester
12/30/2008US7470722 For treating disease, such as cancer, neurological disorders, including polyglutamine-repeat disorders, anemias, thalassemias, inflammatory conditions, autoimmune diseases and cardiovascular conditions
12/30/2008US7470713 Imidazole based kinase inhibitors
12/30/2008US7470712 Amino-benzazoles as P2Y1 receptor inhibitors
12/30/2008US7470710 Such as 2-Benzofuranylmethyl-1-((5-(4-fluorophenyl)-2-methyl-thiazolyl) carbonyl)piperidine; obesity, type 2 diabetes, sleep disorders; strokes, blocking emetic response
12/30/2008US7470709 Benzimidazole quinolinones and uses thereof
12/30/2008US7470701 e.g. 3-(4-fluorophenyl)-N-{5-[2-(methylamino)pyrimidin-4-yl]thien-2-yl}propanamide; PKB/Akt kinase inhibitor; anticarcinogenic agent; carcinoma, cancer metastases, squamous cell carcinoma, esophageal squamous cell carcinoma, oral carcinoma, cutaneous T cell lymphoma, Hodgkin's lymphoma
12/30/2008US7470699 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/30/2008US7470688 Phthalazinone derivatives
12/30/2008US7470686 e.g. 1,3-benzothiazol-2-yl (2-chloral -4-pyrimidinyl)acetonitrile; Jun N -terminal kinase inhibitor; anticarcinogenic agent; neuronal disorders, autoimmune diseases, cardiovascular disordres
12/30/2008US7470685 e.g. 1-(2-(4-(N'-(3-Methyl-benzylidene)-hydrazino)-6-morpholin-4-yl-pyrimidin-2 -yloxy)-ethyl)-1H-pyridin-2-one; control interleukin production; antiinflammatory, antidiabetic agent; interleukin IL-12 overproduction-related disorder: rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis
12/30/2008US7470681 Pyrimidine compounds
12/30/2008CA2441771C Dihydro-benzo[b][1,4]diazepin-2-one derivatives as mglur2 antagonists i
12/30/2008CA2356300C 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
12/30/2008CA2245587C Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
12/30/2008CA2212207C Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
12/25/2008US20080319191 Crystalline form IV of linezolid
12/25/2008US20080319188 Novel pyridine derivatives and pyrimidine derivatives (3)
12/25/2008US20080319175 Transthyretin Stabilization
12/25/2008US20080319020 4-Oxadiazolyl-Piperidine Compounds and Use Thereof
12/25/2008US20080319011 Protein tyrosine kinase enzyme inhibitors